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compared to AT- and CB-MSC. We have analyzed the molecular
proﬁle of BM-MSC, AT-MSC and CB-MSC. Gene expressions in
BM-MSC preparations correlated with their potential for driving
HPC into self-renewal. Following genes were up-regulated: cad-
herin11, N-cadherin, ITGA1, ITGA5 and ITGB1, VCAM1, pro-
tocadherin18, SDF-1. Western blot analysis also conﬁrmed higher
protein expression of ITGB1, FN1, cadherin11 and N-cadherin in
BM-MSC compared to AT-MSC and CB-MSC.
BM-MSC therefore represent a surrogate model for the human
hematopoietic niche. Primitive subsets of HPC demonstrated a
high afﬁnity to BM-MSC compared to more differentiated frac-
tions. This correlated with the expression of cadherin 11, N-
cadherin and 	1 integrins.
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PREVENTIVE HEALTH BEHAVIORS OF LONG-TERM HEMATOPOIETIC
CELL TRANSPLANT SURVIVORS
Bishop, M.M.1, Beaumont, J.L.2, Lee, S.J.3, Andrykowski, M.A.4,
Rizzo, J.D.5, Wingard, J.R.1 1University of Florida, Gainesville, FL;
2Evanston Northwestern Healthcare, Evanston, IL; 3Fred Hutchinson
Cancer Research Center, Seattle, WA; 4University of Kentucky, Lexing-
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Hematopoietic cell transplantation (HCT) is a life-saving ther-
apy for many patients with leukemia, lymphoma, and breast cancer.
However, it is not known how many, and to what extent, survivors
participate in healthy behaviors and recommended preventive ser-
vices to avoid future health problems after transplant. We collected
self-reported information on health-preserving behaviors as part of
a large, cross-sectional study of long-term HCT survivors, spouses,
and acquaintances. Information on both health provider indepen-
dent (behaviors that do not require medical contact, i.e., tobacco
and alcohol avoidance, exercise) and health provider dependent
(e.g., cholesterol test, blood pressure check, sigmoidoscopy, skin
exam, breast exam, mammogram, immunizations) practices was
obtained through telephone interviews. Participants included 662
HCT survivors (41% allogeneic and 59% autologous) recruited
from 40 North American transplant centers, 177 spouses, 158
controls matched to survivors on sex, age, martial status, and
education level. 238 (36%) of HCT survivors had had acute leu-
kemia, 128 (20%) CML, 131 (20%) lymphoma, and 154 (23%)
breast cancer. Survivors were predominately Caucasian (92%),
married (73%), female (62%), and well-educated (71% had post
high school education). Mean age was 49 yrs (SD10; range 21-77
yrs) and mean time since HCT was 7 yrs (SD 3; range 2-23 yrs).
84% of survivors reported that they never smoke, 59% never drink
alcohol, and 35% often/always exercise at least 20 minutes/day 3
times/week. Despite 94% of survivors reporting they had a physi-
cian and 92% having health insurance coverage, only 56% of
survivors reported having received a ﬂu shot in the last year.
Although allogeneic survivors were more likely than autologous
survivors to report having had a skin exam in the past year (54% vs.
43%, p.002), those rates were low given their vulnerability to
skin cancer. Additional comparisons between type of transplant, as
well as time since transplant and cohort group (survivors, spouses,
matched controls) are underway. Overall self-reported compliance
with recommended health behaviors in HCT survivors was rea-
sonably good compared to the general population, but there re-
mains considerable room for improvement. Survivors’ frequent
contact with the medical system and past experience with illness
provide opportunities to improve prevention screening and to
promote healthy behaviors in HCT survivors and their families.
126
HEMATOPOIETIC STEM CELL TRANSPLANTATION (SCT) IN FANCONI
ANEMIA (FA) PATIENTS: HOW LONG IS LONG TERM FOLLOW-UP?
Bonﬁm, C.1, Bitencourt, M.1, deMedeiros, C.1, Setubal, D.1, Ruiz, J.1,
Quiroga, M.1, Beltrame, M.1, Funke, V.1, Zanis-Neto, J.1,
Pasquini, R.1 1Stem Cell Transplantation Center - Federal University of
Parana, Curitiba, PR, Brazil.
FA is an autosomal recessive disorder characterized by progres-
sive bone marrow failure, congenital abnormalities and a predis-
position to malignancies. SCT is the only treatment that can
restore normal hematopoiesis but long term follow up(LTFU) is
essential especially because of the high incidence of cancer in
these pts. From 1983 to 2006, 168pts were transplanted in our
BMT Unit. In this study we evaluated the outcome of 43 pts
transplanted between 1983-1996 from related bone marrow
compatible donors. Aplastic phase:40pts, MDS/Leukemia:3pts.
No radiotherapy was given in the preparatory regimen. 36/43pts
survived 28d and were evaluable for engraftment. 34 had a
sustained hematological engraftment and 2pts had a partial
engraftment. One pt with previous MDS relapsed and died after
a 2nd BMT. No other pt rejected their graft. 19pts died between
1-3101d after SCT(M:48d) due to infections or
hemorrhage(13pts), tongue carcinoma(2pts) and extensive C-
GVHD/ infections (5pts). Twenty-four pts are alive between
10-18,3years after BMT(M:12,4years). Median age was 8y(3-32)
at SCT and 20,5y(13-47) at most recent evaluation.Gender:9F/
15M. Aplastic phase: all pts. Preparatory regimen: CY200: 3pts;
CY140ATG:8pts; CY120:4pts; Cy100:9pts. GVHD prophy-
laxis: cyclosporine (Csa)MTX: 20pts; Csa  steroids:4pts.
Mucositis grade II-IV occurred in 19pts and severe hemorrhage
in 5pts. A-GVHD grade II-III: 2pts. Extensive C-GVHD:
2pts.Chimerism was evaluated by VNTR analysis in 21 pts and
by cytogenetics or blood type in 3 pts. All pts have normal blood
counts and only 3 pts had a mixed chimerism (80-90% of
donor’s cells). One pt developed esophagus stenosis after SCT
due to severe mucositis. 18pts were transplanted before the age
of 12y and only 2pts(female/male) needed hormonal replace-
ment to enter puberty. Reproductive function: Only 2pts be-
came pregnant 6y and 11 y after SCT. One of them delivered a
healthy child and the other had a spontaneous abortion. Hypo-
thyreoidism was detected in 2pts. Malignancies developed in
2/24pts (basal cell carcinoma and tongue carcinoma). Alto-
gether, 3/43pts developed tongue carcinoma. All of them had
grade IV mucositis and only one had severe acute and chronic
GVHD. Conclusion: FA pts treated with SCT should be care-
fully monitored for life time in order to detect cancer and other
complications.
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GENE EXPRESSION SIGNATURES THAT PREDICT HUMAN RADIATION
EXPOSURE
Meadows, S.1, Dressman, H.1, Muramoto, G.1, Chao, N.J.1,
Ginsburg, G.1, Nevins, J.P.1, Chute, J.P.1 1Duke University Medical
Center, Durham, NC.
The capacity to assess environmental inputs to biological
phenotypes is limited by methods that can accurately and quan-
titatively measure these contributions. One such example can be
seen in the context of exposure to ionizing radiation. The
purposeful detonation of radiological or nuclear materials by
terrorists has been recognized as a major threat to U.S. national
security. Unfortunately, no rapid or practical assays are available
to measure internal biodosimetry in a large population of af-
fected individuals. To address this problem, we have made use
of gene expression analysis of peripheral blood mononuclear
cells (PB MNCs) to develop expression proﬁles that accurately
reﬂect prior radiation exposure. Importantly, we demonstrate
that expression proﬁles can be developed that not only predict
radiation exposure in mice but also distinguish the level of
radiation exposure, ranging from 50 cGy to 1000 cGy. Likewise,
a molecular signature of radiation response developed solely
from analysis of peripheral blood samples from irradiated stem
cell transplant patients can predict and distinguish irradiated
human PB samples from non-irradiated samples with an accu-
racy of 90%, sensitivity of 85% and speciﬁcity of 94%. We
further demonstrate that a radiation proﬁle developed in the
mouse can correctly distinguish PB samples from irradiated and
non-irradiated human patients with an accuracy of 77%, sensi-
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